Table 3.
Rest | Exercise peak | 1 min | 3 min | 5 min | 7 min | 9 min | |
---|---|---|---|---|---|---|---|
Hypogonadal subjects | |||||||
RR (ms) | 929 ± 204 | 467 ± 83 | 581 ± 120 | 670 ± 176 | 679 ± 128 | 687 ± 151 | 694 ± 44 |
QTe (ms) | 401 ± 33* | 297 ± 50 | 315 ± 41* | 332 ± 47 | 346 ± 38* | 351 ± 52* | 339 ± 42* |
QTeBazett (ms) | 430 ± 33* | 436 ± 57 | 416 ± 47 | 410 ± 44 | 422 ± 29* | 425 ± 44 | 411 ± 41 |
QTeFridericia (ms) | 423 ± 27* | 383 ± 52 | 378 ± 41 | 381 ± 40 | 395 ± 29* | 398 ± 44 | 385 ± 37 |
QTeLilly (ms) | 426 ± 29* | 404 ± 54 | 393 ± 42 | 392 ± 41 | 405 ± 28* | 409 ± 44 | 395 ± 38 |
QTeFramingham (ms) | 422 ± 28* | 379 ± 44 | 379 ± 32* | 383 ± 37 | 396 ± 26* | 399 ± 41 | 387 ± 33 |
Control subjects | |||||||
RR (ms) | 869 ± 203 | 407 ± 50 | 506 ± 100 | 574 ± 110 | 605 ± 126 | 604 ± 106 | 603 ± 158 |
QTe (ms) | 371 ± 27* | 263 ± 47 | 278 ± 30* | 303 ± 30 | 306 ± 28* | 313 ± 23* | 297 ± 53* |
QTeBazett (ms) | 402 ± 25* | 411 ± 62 | 392 ± 28 | 402 ± 23 | 396 ± 16* | 404 ± 17 | 384 ± 39 |
QTeFridericia (ms) | 391 ± 15* | 354 ± 56 | 349 ± 26 | 365 ± 21 | 363 ± 15* | 371 ± 14 | 352 ± 43 |
QTeLilly (ms) | 395 ± 18* | 376 ± 58 | 366 ± 26 | 379 ± 21 | 376 ± 14* | 384 ± 14 | 364 ± 42 |
QTeFramingham (ms) | 391 ± 17* | 354 ± 43 | 354 ± 20* | 368 ± 18 | 367 ± 13* | 374 ± 12 | 358 ± 34 |
Hypogonadal subjects | |||||||
QTp (ms) | 314 ± 23* | 214 ± 23 | 214 ± 23 | 258 ± 34* | 269 ± 33* | 270 ± 45 | 273 ± 27* |
QTpBazett (ms) | 323 ± 20* | 314 ± 16 | 283 ± 17 | 318 ± 22* | 328 ± 28* | 326 ± 34 | 331 ± 24* |
QTpFridericia (ms) | 322 ± 20** | 276 ± 17 | 257 ± 16 | 296 ± 23* | 307 ± 27* | 306 ± 36 | 310 ± 20* |
QTpLilly (ms) | 325 ± 21** | 291 ± 16 | 257 ± 16 | 304 ± 22* | 315 ± 27* | 314 ± 35 | 319 ± 21* |
QTpFramingham (ms) | 325 ± 26* | 296 ± 13 | 278 ± 13 | 309 ± 20* | 744 ± 105 | 318 ± 30 | 321 ± 19* |
Control subjects | |||||||
QTp (ms) | 276 ± 23* | 202 ± 32 | 202 ± 33 | 220 ± 25* | 230 ± 30* | 243 ± 25 | 233 ± 41* |
QTpBazett (ms) | 299 ± 16* | 316 ± 41 | 285 ± 39 | 292 ± 22* | 297 ± 30* | 315 ± 29 | 301 ± 27* |
QTpFridericia (ms) | 291 ± 13* | 272 ± 37 | 254 ± 35 | 266 ± 20* | 272 ± 27* | 289 ± 25 | 276 ± 32* |
QTpLilly (ms) | 294 ± 12* | 289 ± 39 | 266 ± 37 | 276 ± 21* | 282 ± 28* | 299 ± 26 | 286 ± 30* |
QTpFramingham (ms) | 296 ± 16** | 293 ± 28 | 278 ± 27 | 286 ± 16* | 279 ± 27* | 304 ± 20 | 294 ± 22* |
Hypogonadal subjects | |||||||
Te (ms) | 79 ± 10 | 76 ± 17 | 88 ± 27 | 83 ± 10 | 75 ± 15 | 78 ± 10 | 78 ± 20 |
TeBazett (ms) | 99 ± 11 | 112 ± 25 | 117 ± 42 | 103 ± 12 | 92 ± 17 | 94 ± 11 | 96 ± 28 |
TeFridericia (ms) | 92 ± 10 | 98 ± 21 | 106 ± 35 | 95 ± 10 | 86 ± 16 | 88 ± 10 | 90 ± 25 |
TeLilly (ms) | 94 ± 10 | 103 ± 23 | 110 ± 38 | 98 ± 11 | 88 ± 16 | 90 ± 10 | 92 ± 27 |
TeFramingham (ms) | 132 ± 18 | 158 ± 18 | 152 ± 32 | 133 ± 24 | 125 ± 19 | 126 ± 22 | 126 ± 33 |
Control subjects | |||||||
Te (ms) | 70 ± 12 | 65 ± 16 | 76 ± 14 | 102 ± 65 | 96 ± 71 | 96 ± 73 | 96 ± 76 |
TeBazett (ms) | 94 ± 17 | 102 ± 22 | 107 ± 18 | 137 ± 93 | 126 ± 98 | 124 ± 98 | 124 ± 100 |
TeFridericia (ms) | 85 ± 15 | 88 ± 20 | 95 ± 16 | 124 ± 82 | 85 ± 16 | 114 ± 88 | 114 ± 91 |
TeLilly (ms) | 87 ± 16 | 93 ± 21 | 100 ± 17 | 129 ± 86 | 119 ± 92 | 119 ± 92 | 118 ± 95 |
TeFramingham (ms) | 137 ± 19 | 157 ± 13 | 152 ± 18 | 167 ± 69 | 157 ± 75 | 157 ± 75 | 157 ± 79 |
These data are detected manually with tangential method. *p < 0.05 or **p < 0.001: hypogonadal patients vs controls
RR RR interval, QTe QT end, QTp QT peak, Te T end